SCHEMBL7079244

SCHEMBL7079244

Cc1ccccc1Nc1ccc(C(=O)c2ccncc2Cl)c(Cl)c1

nearest known ligand 0.75

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 13/20 0.75
MAPK13 O15264 12/20 0.75
MAPK12 P53778 12/20 0.75
MAPK11 Q15759 12/20 0.75
CCNA2 P20248 2/20 0.46
CDK2 P24941 2/20 0.46
IMPDH2 P12268 1/20 0.46
LMNA P02545 1/20 0.43
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
KMT2A Q03164 1/20 0.43
PTGS1 P23219 1/20 0.42
PTGS2 P35354 1/20 0.42
TP53 P04637 1/20 0.42
CCNK O75909 1/20 0.42
CCND3 P30281 1/20 0.42
CDK9 P50750 1/20 0.42
CDK6 Q00534 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7034038 0.88 MAPK14 (0.76) MAPK14MAPK13MAPK12MAPK11IMPDH2
SCHEMBL7075155 0.88 MAPK14 (0.57) MAPK14MAPK13MAPK12MAPK11CCNA2
SCHEMBL1904637 0.86 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11TP53
SCHEMBL7081239 0.86 MAPK14 (0.55) MAPK14MAPK13MAPK12MAPK11CCNA2
SCHEMBL7081236 0.86 MAPK14 (0.55) MAPK14MAPK13MAPK12MAPK11CCNA2
SCHEMBL7039290 0.82 MAPK14 (0.67) MAPK14MAPK13MAPK12MAPK11LMNA
SCHEMBL7082605 0.82 MAPK14 (0.70) MAPK14MAPK13MAPK12MAPK11NPC1
SCHEMBL7033698 0.81 MAPK14 (0.59) MAPK14MAPK13MAPK12MAPK11LMNA
SCHEMBL7080273 0.81 MAPK14 (0.68) MAPK14MAPK13MAPK12MAPK11TP53
SCHEMBL7080441 0.81 MAPK14 (0.68) MAPK14MAPK13MAPK12MAPK11TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US claimed
WO-2002083622-A2 NOVEL AMINOPHENYL KETONE DERIVATIVES LEO PHARMA A/S (DK) 2002-10-24 WO claimed
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US disclosed
WO-2002083622-A2 NOVEL AMINOPHENYL KETONE DERIVATIVES LEO PHARMA A/S (DK) 2002-10-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073832-A1 Novel aminophenyl ketone derivatives MAPKAPK2, MAP3K2, MAP3K1 MAPK14 28/4885MAPK13 33/4885MAPK12 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.